Congressional Trader
Live

WTW congressional trades

7 matched disclosures

Track congressional trades for WTW
Tracked disclosures
7
Lawmakers
3
Buy / sell
5 / 2
Avg post-trade move
N/A
Latest filing 2025-10-10

WTW congressional trades snapshot

This page summarizes public STOCK Act disclosures involving WTW. It is useful for seeing which lawmakers reported WTW transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Oct 10, 2025

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the WTW congressional trade page shows

Congressional Trader tracks 7 public STOCK Act disclosures for WTWacross 3 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent WTW filing shown here was filed on Oct 10, 2025 by Val T. Hoyle as a sale. Related lawmakers include Gilbert Ray Cisneros, Val T. Hoyle, Julie Johnson.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
Val T. HoyleD-ORHouse
No committee data
Filed Oct 10, 2025
Delay 17 days
View filing
Willis Towers Watson Public Limited Company - Ordinary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Val T. HoyleD-ORHouse
No committee data
Filed Sep 12, 2025
Delay 318 days
View filing
WTWNotable
Willis Towers Watson Public Limited Company - Ordinary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Julie JohnsonD-TXHouse
No committee data
Filed May 14, 2025
Delay 37 days
View filing
Willis Towers Watson Public Limited Company - Ordinary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 6, 2025
Delay 29 days
View filing
WTWNotable
Willis Towers Watson Public Limited
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Mar 6, 2025
Delay 10 days
View filing
Willis Towers Watson Public Limited
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Feb 11, 2025
Delay 14 days
View filing
Willis Towers Watson Public Limited
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Feb 11, 2025
Delay 29 days
View filing
WTWNotable
Willis Towers Watson Public Limited Company - Ordinary Shares
Purchase
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded WTW?

Recent WTW disclosures include Gilbert Ray Cisneros, Val T. Hoyle, Julie Johnson.

What is the buy/sell mix for WTW?

The visible sample currently shows 5 purchases and 2 sales or partial sales.

Should I trade based on WTW disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.